SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-139797
Filing Date
2020-12-28
Accepted
2020-12-28 16:36:19
Documents
2
Period of Report
2020-12-28
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2039402d1_8k.htm 8-K 28312
2 EXHIBIT 99.1 tm2039402d1_ex99-1.htm EX-99.1 18658
  Complete submission text file 0001104659-20-139797.txt   48021
Mailing Address 535 BOYLSTON STREET BOSTON MA 02116
Business Address 535 BOYLSTON STREET BOSTON MA 02116 6095104718
Aprea Therapeutics, Inc. (Filer) CIK: 0001781983 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39069 | Film No.: 201418755
SIC: 2834 Pharmaceutical Preparations